John László

6.9k total citations · 1 hit paper
150 papers, 5.2k citations indexed

About

John László is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, John László has authored 150 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 26 papers in Genetics and 25 papers in Oncology. Recurrent topics in John László's work include Acute Lymphoblastic Leukemia research (17 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers) and Chronic Lymphocytic Leukemia Research (12 papers). John László is often cited by papers focused on Acute Lymphoblastic Leukemia research (17 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers) and Chronic Lymphocytic Leukemia Research (12 papers). John László collaborates with scholars based in United States, United Kingdom and Australia. John László's co-authors include Harry Iland, David S. H. Rosenthal, Seamus Murphy, Earl F. Baril, Oliver E. Brown, David Goldstein, Virgil S. Lucas, Joanne Abbotts, Kenneth E. Warner and Louis R. Wasserman and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

John László

144 papers receiving 4.6k citations

Hit Papers

Essential thrombocythemia: an interim report from the Pol... 1986 2026 1999 2012 1986 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John László United States 36 1.4k 1.3k 1.1k 677 495 150 5.2k
Frank A. Oski United States 51 1.1k 0.7× 1.8k 1.4× 2.4k 2.1× 176 0.3× 936 1.9× 254 8.7k
Kari Punnonen Finland 43 1.3k 0.9× 1.4k 1.1× 1.9k 1.6× 475 0.7× 491 1.0× 145 7.4k
Chiara Cerletti Italy 49 1.4k 1.0× 636 0.5× 1.9k 1.6× 650 1.0× 756 1.5× 295 8.6k
Jonathan Glass United States 39 1.3k 0.9× 702 0.5× 1.4k 1.2× 985 1.5× 320 0.6× 163 5.4k
Arthur D. Bankhurst United States 41 1.1k 0.8× 432 0.3× 906 0.8× 796 1.2× 969 2.0× 159 8.1k
Andrew I. Schafer United States 51 2.2k 1.6× 893 0.7× 1.3k 1.2× 381 0.6× 1.0k 2.0× 112 7.0k
Steven Lane United Kingdom 39 2.1k 1.5× 1.2k 0.9× 1.8k 1.6× 801 1.2× 427 0.9× 229 6.1k
Jan van Eys United States 38 960 0.7× 831 0.6× 1.3k 1.1× 301 0.4× 343 0.7× 160 4.7k
Griffin P. Rodgers United States 42 1.5k 1.1× 3.4k 2.6× 2.6k 2.2× 579 0.9× 379 0.8× 174 6.7k
M. Robert Cooper United States 37 908 0.6× 781 0.6× 1.0k 0.9× 3.4k 5.1× 443 0.9× 138 7.3k

Countries citing papers authored by John László

Since Specialization
Citations

This map shows the geographic impact of John László's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John László with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John László more than expected).

Fields of papers citing papers by John László

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John László. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John László. The network helps show where John László may publish in the future.

Co-authorship network of co-authors of John László

This figure shows the co-authorship network connecting the top 25 collaborators of John László. A scholar is included among the top collaborators of John László based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John László. John László is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
László, John, et al.. (2020). Remote GDC hearings. BDJ. 229(4). 210–210.
2.
László, John, et al.. (2020). Consensus, consent and DELPHI. BDJ. 228(11). 816–817.
3.
Detre, Thomas, Daniel E. Ford, Herbert Hendin, et al.. (2003). Confronting Depression and Suicide in Physicians. 20(9). 19 indexed citations
4.
Shiffman, Saul, Barrie R. Cassileth, Joel N. Buxbaum, et al.. (1991). Needs and recommendations for behavior research in the prevention and early detection of cancer. Cancer. 67(S3). 800–804. 7 indexed citations
5.
László, John, et al.. (1990). Breakout I: Ethical considerations. Cancer. 65(S10). 2407–2408. 3 indexed citations
6.
Stoll, Dominik, Powers Peterson, John László, et al.. (1988). Clinical presentation and natural history of patients with essential thrombocythemia and the Philadelphia chromosome. American Journal of Hematology. 27(2). 77–83. 52 indexed citations
7.
Goldstein, Daniel A., J R Dawson, & John László. (1988). Suppression of natural killer cell activity by hydrocortisone.. PubMed. 2(1). 25–30. 5 indexed citations
8.
Krishnan, Ranga, Everett H. Ellinwood, John László, L Hood, & James Ritchie. (1987). Effect of gamma interferon on the hypothalamic-pituitary-adrenal system. Biological Psychiatry. 22(9). 1163–1166. 18 indexed citations
9.
László, John, et al.. (1986). Induction of 2',5'-oligoadenylate synthetase activity in peripheral blood mononuclear cells by gamma interferon.. PubMed. 5(6). 562–70. 3 indexed citations
10.
László, John, et al.. (1983). Phase II trial of lymphoblastoid interferon in metastatic colon carcinoma.. PubMed. 67(11). 1009–12. 11 indexed citations
11.
Hanker, Jacob S., et al.. (1981). Medusa cells: cytostructure and cytochemistry of amoeboid eosinophils with pseudopod-like processes. The Histochemical Journal. 13(6). 905–919. 7 indexed citations
12.
Logue, Gerald L., et al.. (1978). Treatment of chronic granulocytic leukemia with melphalan. Blood. 51(4). 571–577. 8 indexed citations
13.
László, John, et al.. (1978). Comparison of metoprine (DDMP) and etoprine (DDEP) by measuring the inhibition of deoxyuridine incorporation into the DNA of human leukemic cells 1,2,3.. PubMed. 62(3). 341–4. 4 indexed citations
14.
László, John. (1975). Myeloproliferative disorders (MPD): myelofibrosis, myelosclerosis, extramedullary hematopoiesis, undifferentiated MPD, and hemorrhagic thrombocythemia.. PubMed. 12(4). 409–32. 176 indexed citations
15.
Miller, Donald S., et al.. (1972). Reduction of human blood asparagine by hemodialysis. Cancer. 29(5). 1347–1351. 8 indexed citations
16.
Baril, Earl F., et al.. (1971). Deoxyribonucleic acid polymerase with rat liver ribosomes and smooth membranes. Purification and properties of the enzyme. Biochemistry. 10(11). 1981–1992. 121 indexed citations
17.
László, John, et al.. (1965). Reproduction of the Viruses isolated from Cases of Infectious Hepatitis on Detroit-6(VA) Cell Line. Nature. 207(4994). 326–327. 4 indexed citations
18.
László, John, et al.. (1962). Comparative study of mannitol mustard, cyclophosphamide, and nitrogen mustard in malignant lymphomas.. PubMed. 16. 247–50. 7 indexed citations
19.
László, John, et al.. (1962). The metabolic riddle of human peripheral white blood cells: a resolution.. PubMed. 8. 128–33. 6 indexed citations
20.
Burk, Dean, et al.. (1960). Differential Metabolic Responses of Susceptible and Resistant Mouse Leukemia Cells to 8-Azaguanine<xref ref-type="fn" rid="FN1">2</xref>. JNCI Journal of the National Cancer Institute. 24. 57–76. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026